Mario Mendes Leitao, MD
Associate Member
Memorial Sloan Kettering Cancer Center
Dept. of Surgery
1275 York Ave.
New York,
NY
USA
10065
Biographical Sketch: I have been performing gynecologic surgeries with the robotic platform since 2006. Currently, I serve as Co-Director of the Robotic Surgery Program for the Department of Surgery at Memorial Sloan-Kettering Cancer Center. We have been using the robotic platform increasingly for more advanced gynecologic oncology procedures including splenectomy, bowel resections, and tumor cytoreduction. We have published our experience incorporating the platform and continue to analyze our experience."
Papers:
10
Multicenter study comparing two approaches to nodal assessment in patients with low-risk endometrial carcinoma: contemporary sentinel lymph node mapping versus historical selective systematic surgical staging
11
Multicenter study assessing the detection of stage IIIC endometrial cancer in intermediate- and high-risk tumors between a contemporary sentinel node mapping vs. historical comprehensive lymphadenectomy approach
16
Sentinel lymph node mapping using robotic-assisted fluorescence imaging
18
Sentinel inguinofemoral lymph node identification in vulvar cancer and the use of near-infrared imaging for sentinel lymph node detection
22
The impact of intraoperative tumor fragmentation or morcellation in patients with early-stage uterine leiomyosarcoma
24
Impact of circulating tumor cells (CTCs) on overall survival among patients treated with chemotherapy plus bevacizumab for advanced cervical cancer: an NRG Oncology/Gynecologic Oncology Group study
50
Outcomes in low-volume lymph node metastasis discovered during sentinel lymph node mapping for endometrial carcinoma
75
An international comparison of surgically staged patients with serous and clear cell endometrial carcinoma
76
An international comparison of surgical staging approaches in patients with intermediate- and high-risk endometrioid endometrial cancer
77
Outcomes of patients with stage I endometrial cancer in the sentinel lymph node era
80
Do stage I-II uterine clear cell carcinoma patients need to be treated as aggressively as patients with serous carcinoma?
87
An international collaboration for comparison of two approaches to surgical staging of low-risk endometrial cancer
88
Impact of obesity on sentinel lymph node mapping in patients with newly diagnosed uterine cancer undergoing robotic surgery
91
A multicenter prospective assessment of surgical findings associated with suboptimal cytoreduction at primary debulking surgery for advanced ovarian, fallopian tube and peritoneal cancer
104
Improvement in rates of cytoreduction to no residual for stages IIIB-IV ovarian, fallopian tube and primary peritoneal cancer: a change in surgical approach and individualized surgeon feedback
109
Cost-effectiveness analysis of conventional laparoscopic versus robotically assisted laparoscopic adnexal surgery for benign indications performed by gynecologic oncologists
127
International study of primary mucinous ovarian carcinomas managed at tertiary medical centers
183
Radical hysterectomy: programmatic change to reduce laparotomy rate while maintaining oncologic outcome for early stage cervical cancer
244
Sentinel lymph node mapping in patients with vulvar malignancies using indocyanine green and near-infrared imaging: preliminary detection rate experience
292
Combined preoperative and extended pharmacologic venous thromboembolic prophylaxis in patient undergoing surgery for advanced adnexal malignancies
315
Cost-effectiveness analysis of robotically assisted radical hysterectomy for newly diagnosed uterine cervical cancer
355
Impact of smoking on survival among women treated with and without bevacizumab for advanced cervical cancer (CxCA): an NRG Oncology/Gynecologic Oncology Group study
434
Multi-institutional validation of decreased survival with venous thromboembolism in ovarian clear cell carcinoma
446
Predictive value of the age-adjusted Charlson comorbidity index on perioperative complications and survival in patients undergoing surgery for advanced ovarian cancer
495
Survival in patients with uterine carcinosarcoma undergoing sentinel lymph node mapping